• No results found

Molecular dissection of the dysferlin protein complex in skeletal muscle

N/A
N/A
Protected

Academic year: 2021

Share "Molecular dissection of the dysferlin protein complex in skeletal muscle"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Molecular dissection of the dysferlin protein complex in skeletal

muscle

Huang, Y.

Citation

Huang, Y. (2006, September 26). Molecular dissection of the dysferlin protein complex in skeletal muscle. Gildeprint Drukkerijen, Enschede. Retrieved from

https://hdl.handle.net/1887/4573

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4573

(2)

Summary

95

Summary

M utations in dysferlin cause a number of clinically distinctmuscle diseases designated ‘dysferlinopathies’ including a proximal, limb-girdle form of muscular dystrophy (type 2B:LGM D2B) and two forms of distalmyopathy: M iyoshi myopathy (M M ) and distal myopathy with anterior tibial involvement (DM AT). To date, no correlation between the nature or location of the mutation and the clinicalphenotype has been established for these dysferlinopathies. This suggests that additional factors distinct from dysferlin butassociating with dysferlin mightbe involved.

Since dysferlin was identified as disease gene in 1998,caveolin-3,annexins, CAPN3, affixin and DHPR have been implicated to be associated with dysferlin. The work described in this thesis mainly focuses on the identification of the components of the dysferlin protein complex in order to further understand the biologicalfunction of dysferlin in muscle.

To improve the tools for understanding the pathogenesis of the dysferlinopathies, we have selected highly specific heavy chain antibody reagents against dysferlin from a non-immune llama-derived phage display library. By utilizing different truncated forms of recombinant dysferlin for selection and diverse selection strategies, antibody fragments with specificity for two different dysferlin domains could be identified. The selected llama antibody fragments were shown to be functional in W estern blotting, immunofluorescence microscopy and immunoprecipitation. Using these antibody fragments,we found thatCAPN3,which shows a secondary reduction in the dysferlinopathies, is in complex with dysferlin in skeletal muscle (chapter 2).

(3)

Summary

96

marked increase and cytoplasmic localisation in regenerating rat muscle, consistent with the direct interaction between them. Data suggest that dysferlin participates in the recruitment and stabilization of AHNAK to the sarcolemma and that AHNAK plays a role in dysferlin membrane repair process (chapter 3).

Referenties

GERELATEERDE DOCUMENTEN

El paso de una molécula o cargo por el complejo del poro nuclear se denomina transporte núcleo-citoplasmático y se clasifica en importación, cuando es desde

Nup358 provides a platform for disassembly of the trimeric CRM1 nuclear export complex after translocation through the nuclear pore complex, facilitating cargo release and CRM1

After passing University selection exams in June 1994, he moved to Oviedo in Asturias, Spain, where he did university studies in Biology. His passion for

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4573.

The studies presented in this thesis were performed at the Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. The studies

In order to analyze partners in the dysferlin complex by immunoprecipitation, we set out to select single domain antibody fragments against different domains of

Double immunofluorescent analyses of AHNAK and dysferlin in longitudinal normal human skeletal muscle sections showed the colocalization of AHNAK and dysferlin at the

Cells were harvested 48 h after transfection and lysates were analyzed by immunoblotting using rabbit polyclonal KIS (Fig. 3B) antibodies to detect potential